White Paper: Redefining Fibroid Research with Human-Derived Cell Models
To advance fibroid research, Opal Therapeutics has developed lab-grown uterine organoids and cells from menstrual effluent and tissue biopsies. These models offer a suite of research tools to closely mimic how fibroids behave in the body and allow researchers to test how different drugs affect both healthy and fibroid-affected cells.
Bringing the NAMs Revolution to Women's Health
How New Approach Methodologies (NAMs) can shift drug discovery and bring powerful advancements in women’s health
Future of Biotech: Organoids
The FDA’s shift toward organoid-based and AI-powered drug testing marks a new era in biotech. Opal Therapeutics is leading in women’s health with our uterus-in-a-dish platform—using patient-derived uterine organoids to model diseases like endometriosis and fibroids with human-relevant precision.